|
SDAD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.212820E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.131900E-02 |
| Normal-vs-Stage2 |
8.225600E-01 |
| Normal-vs-Stage3 |
4.354200E-01 |
| Normal-vs-Stage4 |
6.698400E-01 |
| Stage1-vs-Stage2 |
4.549200E-01 |
| Stage1-vs-Stage3 |
6.676000E-01 |
| Stage1-vs-Stage4 |
2.626000E-01 |
| Stage2-vs-Stage3 |
7.280600E-01 |
| Stage2-vs-Stage4 |
6.160000E-01 |
| Stage3-vs-Stage4 |
3.890800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.548350E-01 |
| Normal-vs-AfricanAmerican |
1.849980E-01 |
| Normal-vs-Asian |
2.431600E-01 |
| Caucasian-vs-AfricanAmerican |
7.817400E-01 |
| Caucasian-vs-Asian |
7.630400E-01 |
| AfricanAmerican-vs-Asian |
8.340400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.445600E-02 |
| Normal-vs-Female |
8.425800E-01 |
| Male-vs-Female |
1.686030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.252200E-01 |
| Normal-vs-Extreme_Weight |
8.558200E-02 |
| Normal-vs-Obese |
3.905000E-01 |
| Normal-vs-Extreme_Obese |
4.291700E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.644600E-01 |
| Normal_Weight-vs-Obese |
6.270000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.857800E-01 |
| Extreme_Weight-vs-Obese |
4.504800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.503000E-01 |
| Obese-vs-Extreme_Obese |
3.540800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.390200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.463000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.645510E-02 |
| Normal-vs-Age(81-100Yrs) |
1.887960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.768800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.463020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.298770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.773700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.617010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.641800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.212600E-01 |
| Normal-VS-Type2 PRCC |
2.296000E-02 |
| Normal-VS-KIRP CIMP |
4.503200E-01 |
| Normal-VS-Unclassified PRCC |
8.230600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.328810E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.094600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.021400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.704400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.659210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.619400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.376890E-03 |
| Normal-vs-N1 |
6.514400E-01 |
| Normal-vs-N2 |
2.601000E-01 |
| N0-vs-N1 |
2.494300E-02 |
| N0-vs-N2 |
6.931600E-01 |
| N1-vs-N2 |
4.574200E-01 |
|
|
